Professor Brian Drew is an NHMRC Leadership Fellow, and former NHF Future Leader Fellow. He is based at the Baker Heart & Diabetes Institute, Australia, where he holds positions as Head of the Molecular Metabolism and Ageing Laboratory, co-lead of the Obesity & Cardiometabolic Disease Program, and scientific leads of both the In Vivo CRISPR Validation Platform, and the Preclinical Phenotyping Platform. His lab’s research focuses on engaging cutting-edge technologies including systems genetics, CRISPR, lipid nanoparticle therapeutics and phenomics to identify novel diagnostics and therapeutic targets for diseases related to ageing, mitochondrial function and degeneration. His broader group has collectively secured >$13M in competitive funding with his work being published in many leading journals including Nature, Cell Metabolism, Science Transl Med, Nature Commun, Nature Metab and Nature CVR.